Veterinary Medical Specialists

Veterinary Medical Specialists (now SAGE Veterinary Centers) is a leading veterinary specialty group based in Northern California that provides advanced medical, surgical, and emergency care. The organization is highly regarded for its integration of clinical research into veterinary practice, notably participating in the development and clinical testing of Palladia (toceranib phosphate), the first FDA-approved drug for canine cancer. SAGE operates several large-scale specialty hospitals offering services in oncology, internal medicine, cardiology, neurology, and more. Following its merger with Veterinary Surgical Associates and subsequent growth, the company was acquired by National Veterinary Associates (NVA) in 2021.